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ABSTRACT 
   Osteoporosis as a skeletal disorder characterize by compromised bone strength predisposing a person 
to an increased risk of fracture. All people should be encouraged to take efforts to prevent bone loss and 
fractures. Nutrition is one of several factors that can be modified to reduce osteoporosis risk. The 
purpose of this review article is assessment the role of the other nutrients the exception of calcium and 
vitamin D on bone health and prevention of osteoporosis.    
The  search was undertaken in three databases  (PubMed, google scholar and science direct) for 
publications from 2005 onwards using key words as follows. Initial searches yielded approximately 2467 
results. After considering additional exclusion criteria, 33 clinical trial and meta- analysis papers 
remained. 
According to investigations, high intake of dietary protein increase bone resorption and calcium 
excretion and low protein intake can prevent calcium absorption and decrease strength and bone mass. 
Omega-3 supplementation also can decrease bone resorption and α-linleic acid (for men and women) and 
arashidonic acid (in men) and isoflavones can significantly diminish the risk of hip fracture. Adequate 
intake of some nutrients like zinc, vitamin A, boron and manganese in bone formation and copper, 
fluoride and strontium in bone mineralization have positive effects. However, high intake of vitamin A 
and fluoride result in hip fracture incretion. Vitamin K (in form of K2) along with calcium and vitamin D 
induce bone fracture decrease. If intake of phosphate, iron and sodium be more than the recommended 
values, they may present negative effects on bone mineralization.     
In conclusion, risk of osteoporosis incidence may be diminished with an adequate and balanced diet 
containing variety of foods to meet needs and a healthy lifestyle. Nutrition education and training the 
other preventive factors should be carrying out in childhood to achieve the peak bone mass in youth and 
aging. 
 




 Osteoporosis is defined as a skeletal 
disorder characterized by compromised bone 
strength predisposing a person to an increased 
risk of fracture, bone strength reflecting the 
integration of bone density and bone quality [1]. 
Osteoporosis is associated with high morbidity 
and mortality especially because of its 
expression in age related fractures. Childhood 
and adolescence are important for optimal 
formation of bone and for prevention of 
osteoporosis in older age. After the age of 30, 
there is no further increase of bone mass and a 
gradual natural reduction ensues [2]. The first 
fracture incidence in younger age increases the 
risk of a second fracture [3]. Because of 
increase in elderly population, osteoporosis 
appears to become as a major public health 
issue in developing countries as in Iran, even 
though osteoporosis is not exclusive to older 
age [4]. The overall prevalence rate of 
osteoporosis in elderly people was 32.1% in at 
least one measurement sites. Osteoporosis 
prevalence in women was 55.7% and this value 
in elderly men was 12.4% [5]. 
 




With the anticipated increases in world 
population and life expectancy, hip fractures are 
predicted to rise to 6.3 million by 2050. 
Accordingly, the World Health Organization has 
identified osteoporosis as a priority health issue 
and called for a global strategy for the prevention 
and control of the disease [6].  
The aim of osteoporosis management is to 
prevent a first or subsequent fracture by slowing 
or preventing bone loss, maintaining bone 
strength and minimizing skeletal trauma. All 
people should be encouraged to take efforts to 
prevent bone loss and fractures, such as eating a 
balanced diet, participating in appropriate 
weight-bearing exercise, not smoking, avoiding 
excessive alcohol consumption, and instituting 
measures to prevent falls. Nutrition is one of the 
several factors that can be modified to reduce 
osteoporosis risk. A balanced diet is crucial for 
bone development and for general health. 
Calcium and vitamin D have received most of the 
attention directed to diet and bone health, 
moreover, many other nutrients and food 
components can affect bone status [7]. 
The purpose of this review article was to assess 
the role of the other nutrients except calcium and 
vitamin D on bone health and prevention of 
osteoporosis.    
 
MATERIALS AND METHODS 
     The search was undertaken in three databases 
(PubMed, google scholar and science direct) for 
publications from 2005 onwards. The  initial 
search terms were “osteoporosis” and “nutrition” 
later refined by searching for particular terms like 
“macronutrients, micronutrients, trace elements, 
dietary pattern, physical activity, each of macro. 
and micronutrients separately”. 
Initial searches yielded approximately 2467 
results. After considering additional exclusion 
criteria (non-English language, manuscripts not 
available as full-text), 33 papers remained. 
 
RESULTS  
Osteoporosis has multifactorial etiology. 
Osteoporosis is one of diseases which are 
influenced by nutrition and life style (see table 
1). Nutrition management of osteoporosis are 
discussed as these categories: macronutrients, 
micronutrients, trace minerals, other influencing 
factors (alcohol, caffeine, sodium, isoflavone) 




Half of the volume of bone and about one-third 
its mass is made of protein, and this bone 
protein matrix undergoes continuous turnover 
and remodeling [8]. Protein intake affects bone 
in several ways: 1) it provides the structural 
matrix of bone, 2) it optimizes IGF-1 levels, 3) 
it is reported to increase urinary calcium, and 4) 
it is reported to increase intestinal calcium 
absorption [9]. 
Protein deficiency can contribute to the risk of 
osteoporotic fractures and result in failure to 
achieve peak bone mass and in a lack of 
preservation of bone mass during ageing. The 
risk of fracture may be increased not only as a 
consequence of decreased bone mass but also as 
a result of an increased propensity to fall 
because of altered muscle strength and 
impairment of movement coordination [10]. 
Acid-forming foods such as meat, fish, eggs, 
and cereal can increase urinary calcium that is 
likely determined by the acid-base status of the 
total diet. Bone loss may be attributable, in part, 
to the mobilization of skeletal salts to balance 
the endogenous acid generated from acid-
forming foods [9]. 
Fat 
In longitudinal observational study, a-linolenic 
acid (ALA) intake was significantly associated 
with reduced risk of hip fracture in women and 
men, and arachidonic acid (AA) intake was 
significantly associated with reduced risk of hip 
fracture in men but not women. Fish 
consumption (3 serving/wk), intakes of 
eicosapentaenoic acid (EPA), docosahexaenoic 
acid (DHA) and (EPA+DHA) and the (n-6):(n-
3) fatty acid ratio were not associated with hip 
fracture risk [11]. 
Higher saturated fatty acid (SFA) consumption 
was associated with higher hip fracture risk. 
Lower total fracture risk was associated with a 
higher monounsaturated fatty acid (MUFA) 
intake and polyunsaturated fatty acid (PUFA) 
intake. Higher consumption of marine n-3 FAs 
was associated with greater total fracture risk, 
whereas a higher n-6 FA intake was associated 
with a lower total fracture risk. These results 
suggest that saturated FA intake may 
significantly increase hip fracture risk through 
several mechanisms, including opposing effects 
 




on inflammatory cytokine, modulation of 
prostaglandin E2 (PGE2) production, 
enhancement of calcium transport, and reducing 
urinary calcium Excretion, whereas MUFA and 
PUFA intakes may decrease total fracture risk 
[11]. In postmenopausal women with a low 
intake of marine n-3 FAs, a higher intake of n-6 
FAs may modestly decrease total fracture risk 
[12]. 
To evaluate the impact of n-3 fatty acids on 
bone biomarkers, twenty-five osteoporotic 
postmenopausal women were recruited in the 
study and randomized in treatment and control 
groups. The patients received 900 mg n-3 fatty 
acid capsules or placebo per day for 6 months. 
Supplementation with n-3 fatty acids can 
decrease bone resorption; however, it could not 
affect bone formation significantly after 6 
months treatment [13]. 
Conjugated linoleic acid (CLA) as a group of 
PUFAs, contains two conjugated double bonds, 
naturally is found in meat and milk products 
from cattle, lamb, and goat. CLA induces 
retention of bone mineral density (BMD) in 
older mice [14]. Supplementation with CLA for 
14 weeks 2-month-old mice resulted in 
increased BMC and BMD of trabecular and 
cortical bone [15]. 
CLA modulates bone physiology through a 
mechanism dependent on changes of 
peroxisome proliferator-activated receptor 
(PPAR)-γ-mediated induction (a family of 
transcription factors) of adipogenesis of 
mesenchymal cell differentiation to adipocytes 




Phosphate salts are available in all foods either 
naturally or because of processing. Calcium and 
phosphate ions in a ratio of approximately 1: 1 
are needed for the mineralization of bone. Soft 
drinks are poor in nutrient value but high in 
phosphate content. Those at high risk and those 
who have osteoporosis may want to avoid these 
beverages because an effect is theoretically 
possible [17].  
According to the acid-ash hypothesis, increased 
excretion of "acidic" ions such as phosphate, 
contributes to net acidic ion excretion, urine 
calcium excretion, demineralization of bone, and 
osteoporosis. Findings from a meta-analysis were 
contrary to the acid ash hypothesis. When dietary 
phosphate was increased, urine calcium 
decreased, whether the subjects had low or high 
calcium intakes and whether the phosphate 
supplement was neutral/ alkaline or acidic. Three 
of the four calcium balance analyses revealed 
that as phosphate supplements are increased, 
calcium balance increased. However, when the 
phosphate salt was acidic, there was no important 
change in calcium balance. The effect of 
phosphate supplementation on the bone 
metabolism markers did not provide any clear 
information. The increased net acid excretion 
from phosphate supplements in three studies was 
associated with lowered urinary calcium 
excretion [18]. 
Zinc 
Zinc is required for the growth, development, 
and maintenance of healthy bones. In different 
conditions associated with zinc deficiency the 
retardation of bone growth is a common. Zinc 
sulfate caused increases in bone components: 
Alkaline phosphatase is related to bone 
mineralization, Collagen is a main bone matrix 
protein that is produced in osteoblasts, DNA 
content in the bone tissues that is a marker of 
bone cells, including osteoblasts, osetoclasts, and 
osteocytes. Zinc stimulates the production of 
IGF-I and TGF-b1 (bone growth factors) and has 
a stimulatory effect on osteoblastic bone 
formation and mineralization, and an inhibitory 
effect on osteoclastic bone resorption [19]. 
The study was conducted on 224 postmenopausal 
women provided with adequate vitamin D and 
Ca to determine whether increased Cu and Zn 
intakes would reduce the risk for bone loss. 
Healthy women aged 51-80 years were recruited 
for a double-blind, placebo-controlled study. 
Women were randomly assigned to two groups 
of 112 each that were supplemented daily for 2 
years with 600 mg Ca plus maize starch placebo 
or 600 mg Ca plus 2 mg Cu and 12 mg Zn and 
5 d food diaries were obtained annually. Based 
on 5 d food diaries, the negative effect was 
caused by Zn and mainly occurred with Zn 
intakes ≥ 8·0 mg/d. With Zn intakes < 8·0 mg/d, 
Zn supplementation apparently prevented a 
significant decrease in whole-body bone 
densities. The findings indicate that Zn 
supplementation may be beneficial to bone health 
in postmenopausal women with usual Zn intakes 
 




< 8·0 mg/d but not in women consuming adequate amounts of Zn [20]. 
 
Table 1. Selected publications on nutrients affecting the incidence of osteoporosis.  
Publication 
Type of  
Study / 
Duration 





623 Cross-sectionally, both women and men with high fish intakes 
(3 servings/wk) had a greater mean baseline FN-BMD. 
longitudinally between fish intakes and change in BMD over 4 
y in women and men 
(ALA) associated with reduced risk of hip fracture in women 
and men, and (AA) intake was associated with reduced risk of 
hip fracture in men 
Salari Sharif P, et 
al/ 2010 
Case-control 25 osteoporotic 
postmenopausal 
women 
900 mg n-3 fatty acid capsules or placebo per day for 6 months, 
Supplementation with n-3 fatty acids can decrease bone 
resorption; however, it could not affect bone formation 
significantly after 6 months treatment 
Banu J / 2006 Interventional 
/ 14 week 
2-month mice Supplementation with CLA increased BMC, bone area, and 
BMD of trabecular and cortical bone 









Zn supplementation may be beneficial to bone health in 
postmenopausal women with usual Zn intakes < 8·0 mg/d but 
not in women consuming adequate amounts of Zn 
Mackinnon ES, et 







Results showed significantly increased NTx. These findings 
suggest that the daily consumption of lycopene may be 
important as it acts as an antioxidant to decrease bone 
resorption in postmenopausal women and may therefore be 
beneficial in reducing the risk of osteoporosis. 
Gajic-Veljanoski o 
/ 2011 








Supplementation with vitamin K2 to vitamin D3 with calcium 
in postmenopausal women reduced the lifetime probability of at 
least one fracture by 25%, increased discounted survival by 0.7 
quality-adjusted life-years (QALYs).   
vitamin K1, vitamin D and calcium reduced the lifetime 
probability of fracture by 20%, increased discounted survival 
by 0.4 QALYs.  






years or older 
Only 20% of the participants reached the DRI.  
Fractures was reported by 13% of men and 15% of women. 
Women with fractures presented significantly higher calcium, 
phosphorus and magnesium intakes.  
for every 100 mg of phosphorus intake the risk of fractures 
increases by 9% (adverse effects????). 
Odabasi E / 2008 Case-control 77 osteoporotic 





Mg levels in RBC was significantly lower in postmenopausal 
women with osteoporosis. Mg transport mechanism(s) into the 
cell could be affected in patients with osteoporosis. 
No significant difference was found between patient and 
control groups, for zinc, copper, manganese, and selenium 







In comparison with corresponding baseline values, only dried 
plum significantly decreased serum levels of bone turnover 
markers including bone-specific alkaline phosphatase and 
tartrate-resistant acid phosphatase-5b. 
Tsay J / 2010 Case - control 8 male mice of 2-
month-old 
Iron-overloaded mice exhibited: 
Dose-dependent increased tissue iron content, Changes in bone 
composition, Trabecular and cortical thinning of bone, 
Increased bone resorption 
Pejović-Milić A, et 
al /2009 
Case - control 40 subjects (30 
welders and 10 
controls) 
The mean bone Mn levels were higher than for welders that 
showed bone Mn levels do reflect differences in the 
occupational exposure of Mn 
Bae YJ, et al / 2008 Interventional ovariectomized 
rats/12 week 
Serum C-telopeptide cross-links of type I collagen (CTx), and 
alkaline phosphatase (ALP), were not significantly different 
among the four groups. serum osteocalcin was significantly 
increased by Mn supplementation resulted in Mn 
supplementation increased BMD and bone formation. 
 






Vitamin A consumption has beneficial effects 
on bone growth and maintenance. Lycopene 
may be protective against oxidative stress and 
bone resorption. 23 healthy postmenopausal 
women, 50–60 years old, provided blood 
samples at baseline and following a one-month 
lycopene-depletion period. Serum samples were 
analyzed for carotenoids and the bone turnover 
markers bone alkaline phosphatase and 
crosslinked N-telopeptide of type I collagen 
(NTx). Results showed significantly increased 
NTx that suggested the daily consumption of 
lycopene may be important as it acts as an 
antioxidant to decrease bone resorption in 
postmenopausal women and may therefore be 
beneficial in reducing the risk of osteoporosis 
[21]. Excessive retinol intake (but not 
carotenoids) may contribute to risk for hip 
fractures. The inconsistencies may be due, in 
part, to difficulties in obtaining an accurate 
assessment of vitamin A intake or status. Serum 
retinol is a poor measure of vitamin A status 
because it is subject to homeostatic control. 
Stable-isotope-dilution methodology gives a 
validated assessment of the total-body and liver 
vitamin A stores and is recommended in future 
studies on vitamin A status and osteoporosis. 
The potential for exacerbating an already 
serious public health problem with intakes of 
vitamin A currently considered safe indicates 
further research into this matter is warranted 
[22]. 
Vitamin K 
Vitamin K has role in posttranslational 
modification of several matrix proteins, including 
osteocalcin. Following bone resorption, 
osteocalcin is released and enters the blood ( 
osteocalcin serves as a serum bone marker for 
predicting the risk of a fracture ). Vitamin K 
intakes in older persons who may also be taking 
vitamin K antagonists are low [23]. 
Supplementation with vitamin K2 to vitamin D3 
with calcium in postmenopausal women reduced 
the lifetime probability of at least one fracture by 
25%, increased discounted survival by 0.7 quality-
adjusted life-years (QALYs). Vitamin K1, vitamin 
D and calcium reduced the lifetime probability of 
fracture by 20%, increased discounted survival by 
0.4 QALYs. The efficacy of vitamin K was the 
most important parameter in sensitivity analyses. 
Conclusions Lifetime supplementation with 
vitamin K, vitamin D3, and calcium is likely to 
reduce fractures and increase survival in 
postmenopausal women. [24]. 
Magnesium 
Magnesium deficiency may affect the quality of 
bone by decreasing bone formation, preventing 
the optimal crystal formation, having a negative 
effect on PTH [25]. In a transversal population-
based study, a total of 2420 individuals over 40 
years old were evaluated for nutrient intakes. 
Fractures were reported by 13% of men and 15% 
of women. In all regions and socio-economical 
levels mean intakes of bone related nutrients were 
below the recommended levels. It was 
demonstrated that for every 100 mg/phosphorus 
increase the risk of fractures by 9% [26]. 







Lumbar BMD increased continuously and significantly, over 10 
years. 
Hallstrom H, et al / 
2010 
Cohort study 
/ 2 years 
359 men and 358 
women (aged 72 
years) 
A high consumption of coffee (i.e. 4 cups or more per day) 
could contribute to a reduction in BMD of the proximal femur 
in elderly men. BMD was lower in high consumers of coffee 
with rapid metabolism of caffeine. 
Haghighian A / 
2005 
Interventional 




Soy protein consumption resulted in a significant reduction in 
the urinary deoxypyridinoline and increasing of total alkaline 
phosphatase, although the alterations in osteocalcin, c-
telopeptide, IGFBP3 and type I collagen telopeptide were not 
significant. 
Wosje KS / 2010 longitudinal 
study / 4 
years 
308 children High intake of dark green and deep-yellow vegetables was 
related to high bone mass; high processed-meat intake was 
related to high bone mass; and high fried-food intake was 
related to high fat mass. 
Cole ZA / 2009 longitudinal 
study / 9 
years 
198 pregnant 
women 17–43 yr 
of age and their 
offspring at 9 yr 
of age 
Higher prudent diet score in late pregnancy was associated with 
greater whole body and lumbar spine BMC and areal BMD in 
the offspring at 9 yr of age. Associations with prudent diet 
score in early pregnancy were weaker and non significant. 
 




Seventy-seven postmenopausal women with 
osteoporosis aged 61 years and 61 age- and BMI-
matched healthy postmenopausal women aged 60 
years were included in the study to evaluate 
element concentrations in plasma and red blood 
cells. Only statistically significant difference 
between the osteoporotic and healthy subjects was 
observed in red blood cell (RBC) magnesium 
concentration. Mg levels in red blood cells are 
significantly lower in postmenopausal women 
with osteoporosis. It is concluded that Mg 
transport mechanism(s) into the cell could be 




Prunes are a rich source of boron and raisins, 
dried apricots, or avocados are the other source. 
Boron is used by osteoblasts for bone formation 
[28]. It is required to convert estrogen to its 
most active form, 17-betaestradiol, and estrogen 
is involved in bone metabolism. Boron 
stabilizes and extends the half-life of vitamin D 
and estrogen [29].  
Bone marrow stromal cells (BMSCs) 
proliferation and cell osteogenic differentiation 
was evaluated [through alkaline phosphatase 
(ALP) activity] by Ying and his colleages. The 
results indicated that the proliferation of 
BMSCs was no different from the control group 
when added with boron at the concentration of 
1, 10, and 100 ng/ml respectively [30]. 
To examine the extent to which dried plum 
reverses bone loss in osteopenic 
postmenopausal women, the study was carried 
out on 236 women, 1-10 years postmenopausal, 
not on hormone replacement therapy or any 
other prescribed medication known to influence 
bone metabolism. Qualified participants (n 160) 
were randomly assigned to one of the two 
treatment groups: dried plum (100 g/d) or dried 
apple (comparative control). Dried plum 
significantly increased BMD of ulna and spine 
in comparison with dried apple. In comparison 
with corresponding baseline values, only dried 
plum significantly decreased serum levels of 
bone turnover markers including bone-specific 
alkaline phosphatase and tartrate-resistant acid 
phosphatase-5b after 12 months [31]. 
Copper 
Copper is needed for enzyme that increases the 
crosslinking of collagen and elastin molecules. 
It may have roles in other enzymes of bone 
cells. Because of the changes induced in the two 
matrix proteins by low copper intakes, bone 
mineralization may also be reduced. There is no 
significant difference between the 
postmenopausal women with and without 
osteoporosis in terms of Cu levels in plasma and 
in RBC [27]. 
In Nielsen’s study, findings also indicated that 
the greatest decreases in bone loss occurred 
with Cu and Zn supplementation. Food diaries 
also indicated that Mg intakes < 237 mg/d, Cu 
intakes < 0·9 mg/d and Zn intakes < 8·0 mg/d 
are associated with poorer bone health [20]. 
Fluoride 
Fluoride ions enter the hydroxyapatite crystals 
of bone. Fluoride ions have little effect on 
increasing the hardness of bone mineral. At 
intakes of 2 ppm or greater, fluoride may 
produce bone that is subject to increased micro 
fractures because of the change in the properties 
of the hydroxyapatite crystals [28]. 
Meta-analysis indicates that beneficial anabolic 
effects may dominate at lower doses of fluoride 
(≤20 mg/day fluoride equivalents. The used 
doses of fluoride equivalents there is a marked 
and clinically significant increase in BMD 
especially in the spine but also in the hip 
without any reduction in vertebral or non-
vertebral fracture risk with increasing treatment 
duration 
(5.04±2.16%/year of treatment). Spine BMD 
increased 7.9% and hip BMD 2.1%. Low dose 
fluoride reduced vertebral fractures by 72% and 
non-vertebral fractures by 48% [32]. 
Iron 
Iron serves as a catalytic cofactor for the 
vitamin C-dependent hydroxylations of proline 
and lysine in collagen maturation. Iron also has 
other roles in osteoblasts and osteoclasts in 
mitochondrial oxidative-phosphorylation, as 
well as in other heme- and non heme-containing 
enzymes [28]. Tsay & colleagues generated an 
iron-overloaded mouse by injecting iron dextran 
at 2 doses into mice for 2 months to define the 
effect of iron excess in bone. Compared with 
the placebo group, iron-overloaded mice 
exhibited dose-dependent increased tissue iron 
content, changes in bone composition, and 
trabecular and cortical thinning of bone 
accompanied by increased bone resorption. 
Liver and spleen iron content were markedly 
 




increased. Although bone iron content was also 
increased in iron-treated mice compared with 
placebo, the increase was not as pronounced as 
in liver and spleen. Analysis of cortical bone 
(mid-diaphysis femur) in the iron-overloaded 
animals showed thinner cortices and decreased 
cortical area compared with controls [33]. 
Manganese 
Manganese is required for the biosynthesis of 
mucopolysaccharides in bone matrix formation, 
and it also acts as a cofactor in energy-
generating reactions. There is a need for a 
diagnostic tool with the ability to measure 
cumulative exposure to manganese (Mn) in the 
workplace. Bone Mn levels of welders were 
measured and compared to the levels found in 
subjects without exposure to the element in a 
study. Forty subjects (30 welders and 10 
controls) were recruited. An occupational 
history was obtained and subjects underwent in 
vivo neutron activation analysis (IVNAA) bone 
Mn measurements. The mean bone Mn levels 
were higher than for welders. It appears that 
bone Mn levels do reflect differences in the 
occupational exposure of Mn [34]. 
The effect of manganese (Mn) supplementation 
on bone mineral density (BMD) and bone 
metabolism parameters was determined in 
ovariectomized rats. Rats were divided into four 
groups and fed with different intake levels of 
manganese for 12 weeks. BMD of the lumbar 
vertebrae, femur, and tibia were significantly 
lowered in ovariectomized rats compared to the 
sham group. In addition, BMD of the lumbar 
vertebrae was significantly increased by Mn 
supplementation in the sham groups. Serum C-
telopeptide cross-links of type I collagen (CTx), 
bone resorption biomarker; alkaline phosphatase 
(ALP), and bone formation biomarkers were not 
significantly different among the four groups. 
However, serum osteocalcin, a more sensitive 
bone formation biomarker, was significantly 
increased by Mn supplementation. To 
summarize, Mn supplementation resulted in 
increased BMD and bone formation [35].  
Strontium 
Strontium has gained attention for bone 
mineralization because it increases bone density 
as measured by DXA Scan. Strontium is 
considered an alkaline earth metal, that makes it 
much heavier than calcium and it replaces 
natural calcium in bone. Strontium ranelate in 
doses of 2 gram/day have been used for the 
treatment of osteoporosis in several countries. 
Strontium ranelate has proven efficacy against 
vertebral and nonvertebral fractures, including 
hip, over 5 years in postmenopausal 
osteoporosis. Long term efficacy and safety of 
strontium ranelate was explored over 10 years. 
Postmenopausal osteoporotic women 
participating in the double-blind, placebo-
controlled studies, Spinal Osteoporosis 
Therapeutic Intervention (SOTI) and Treatment 
of Peripheral Osteoporosis (TROPOS) trials, 
were invited to enter a 5- year open-label 
extension, during which they received strontium 
ranelate 2 g/day (n=237, 10-year population). 
Lumbar BMD increased continuously and 
significantly, over 10 years. Long-term 
treatment with strontium ranelate is associated 
with sustained increases in BMD over 10 years, 
with a good safety profile. Our results also 
support the maintenance of antifracture efficacy 
over 10 years with strontium ranelate [36]. 
Overall, the clinical data available suggest that 
strontium ranelate is an effective and generally 
well tolerated option for the first-line treatment 
of postmenopausal osteoporosis [37]. 
 
Other influencing factors 
Alcohol 
Moderate consumption of wine and beer may be 
beneficial to bone in men and postmenopausal 
women. In men, high liquor intakes (>2 
drinks/d) are associated with significantly lower 
BMD. Heavy alcohol consumption also may be 
accompanied by poor dietary intake, cigarette 
smoking, body imbalance, and an increased risk 
of falls [17]. 
Caffeine and Soft Drinks 
Excessive caffeine intake has a deleterious 
effect on BMD. Intake of colas is also 
associated with lower BMD. Although the 
primary issue may be displacement of dairy 
beverages, there is also potential direct effect 
[38]. Dietary intakes of 359 men and 358 
women (aged 72 years) were assessed by a 7-
day food diary. Two years later, BMD for total 
proximal femur, femoral neck and trochanteric 
regions of the proximal femur were measured 
by Dual-energy X-ray absorptiometry (DXA). 
In this cohort the consumption of coffee was 
high and they observed a decrease in BMD of 
the proximal femur in men consuming 4 cups of 
 




coffee or more daily. In high consumers of 
coffee, rapid metabolizers had lower BMD 
values than slow metabolizers of caffeine. A 
potential risk group more prone to develop 
osteoporosis might, thus, have been identified. 
The observed decrease in BMD in male high 
consumers of coffee could be estimated to 
correspond to an approximately 30% increased 
risk of hip fracture. A high consumption of 
coffee (i.e. 4 cups or more per day) could 
contribute to a reduction in BMD of the 
proximal femur in elderly men. BMD was lower 
in high consumers of coffee with rapid 
metabolism of caffeine, suggesting that this 
group of coffee consumers might be at special 
risk of bone loss [39]. 
Sodium 
It’s not demonstrated that bone sodium has a 
critical role in bone mineral properties or in 
calcium homeostasis. While investigations was 
suggested that bone sodium plays a role in total 
body sodium homeostasis, the major view is 
that bone is at most a passive participant in ECF 
sodium homeostasis. A high sodium intake may 
contribute to osteoporosis because of increased 
calcium excretion. Excesses intake of sodium, 
in the form of sodium chloride, elevates urinary 
calcium excretion and, at prevailing calcium 
intakes, evokes compensatory responses that 
may lead to increased bone remodeling and 
bone loss. The calciuria is partly due to salt-
induced volume expansion, with an increase in 
Glomerolar Filtrating Rate (GFR), and partly to 
competition between sodium and calcium ions 
in the renal tubule. Potassium intakes in the 
range of current recommendations actually 
reduce or prevent sodium chloride-induced 
calciuria. At calcium intakes at or above 
recommended levels, there appear to be no 
harmful effects of excessive salt intakes on bone 
or the calcium, mainly because adaptive 
increases in calcium absorption offset the 
increased urinary loss. It would seem that the 
optimal strategy to protect the skeleton is to 
ensure adequate calcium and potassium intakes 
[40]. 
Isoflavones 
Soy isoflavones as natural phytoestrogens have 
weak estrogen agonistic effect on estrogen 
receptor β, which make them similar to selective 
estrogen receptor modulators (SERMs). 
Isoflavones (including daidzin, daidzein, 
genistin, and genistein) are present in soybeans 
at relatively high concentrations. Genistein or 
daidzein has been demonstrated to have a direct 
anabolic effect on bone metabolism in vitro, 
suggesting their role in the prevention of 
osteoporosis. Genistein as a food factor is useful 
in the prevention and therapy of osteoporosis 
[19].  
In clinical trial of before-after type was carried 
out on 15 women 45–64 years of age, subjects 
were given 35 g soy protein provided 98 mg of 
isoflavones per day for 12 weeks. Soy protein 
consumption in postmenopausal women after 12 
weeks resulted in a significant reduction in the 
urinary dpy (resorption marker) and increasing 
of total alkaline phosphatase, although the 
alterations in osteocalcin, c-telopeptide, 
IGFBP3 and type I collagen telopeptide were 
not significant. Therefore, in view of beneficial 
effect of soy protein on bone metabolism 
indicators, inclusion of this relatively 
inexpensive food in the daily diet of 
menopausal women, will probably delay bone 
resorption, thereby preventing osteoporosis 
[41]. 
 Results of Meta-analysis indicate that 
phytoestrogens prevent bone resorption, but its 
benefits on bone formation are not significant in 
low doses and in at least 3 weeks of intake. 
Therefore, 
phytoestrogens seems beneficial in decreasing 
bone resorption in postmenopausal women, and 
to date, no advantage on bone formation has 
been determined [42]. 
Dietary patterns 
Health and growth are affected by dietary intake 
through single nutrients and interactions among 
nutrients. Finding of the study to identify 
dietary patterns related to fat and bone mass in 
children during the age period of 3.8–7.8 y 
showed that increasing intakes of dark-green 
and deep yellow vegetables and limiting fried-
food intake may promote healthy fat and bone 
mass accrual [43]. The biological process by 
which dark-green and deep-yellow vegetables 
(eg, spinach, romaine lettuce, broccoli, carrots, 
and sweet potatoes) affect bone mass, remains 
unclear, but may be related to their high content 
of alkalizing minerals such as potassium. 
Higher dietary potassium intake is related to 
lower net endogenous acid production and to a 
higher bone mass in adults [44]. Training at 
 




preschool age, diets rich in dark-green and 
deep-yellow vegetables and low in fried foods 
may lead to healthy fat and bone mass in young 
children. 
A high prudent diet score was characterized by 
elevated intakes of fruit, vegetables, and 
wholemeal bread, rice, and pasta and low 
intakes of processed foods. Higher prudent diet 
score in late pregnancy was associated with 
greater whole body and lumbar spine BMC and 
areal BMD in the offspring at 9 yr of age. 
Associations with prudent diet score in early 
pregnancy were weaker and non- significant 
[45]. 
CONCLUSIONS 
   Nutritional management for prevention of 
osteoporosis can be implemented by suitable 
food choice and healthy dietary pattern. 
Because of the vital role of nutrition in 
preventing or delaying the incidence of 
osteoporosis, it is necessary to include variety of 
foods in usual diet. When nutritional needs are 
met through diet, may be supplementation is 
generally unnecessary. However, nutrient 
supplementation might be needed for some high 
risk groups like children or aged people. 
According to investigations, high intake of 
dietary protein increase bone resorption and 
calcium excretion and low protein intake can 
prevent calcium absorption and decrease 
strength and bone mass. Omega-3 
supplementation also can decrease bone 
resorption and α-linleic acid (for men and 
women) and AA (in men) and isoflavones can 
significantly diminish the risk of hip fracture. 
Adequate intake of some nutrients like zinc, 
vitamin A, boron and manganese in bone 
formation and copper, fluoride and strontium in 
bone mineralization have positive effects. 
However, high intake of vitamin A and fluoride 
result in hip fracture incretion. Vitamin K (in 
form of K2) along with calcium and vitamin D 
induce bone fracture decrease. If intake of 
phosphate, iron and sodium be more than the 
recommended values, they may present negative 
effects on bone mineralization.     
In conclusion, risk of osteoporosis incidence 
may be diminished with an adequate and 
balanced diet containing variety of foods to 
meet needs and a healthy lifestyle. Nutrition 
education and training the other preventive 
factors should be carrying out in childhood to 
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